latest update:
[TrialBase DB]

trial summary · NCT06553651

Necrosectomy With Cryotechnology for Accelerated Removal

Trial record from the TrialBase DB dataset, status RECRUITING, condition Pancreatic Necrosis, sponsored by Christopher C. Thompson, MD, MSc. Facts below are exported values from the current release, not inferred or edited prose.

registry NCT06553651phase —enrollment 20start 2026-12

Summary

The brief summary is the registry's published description, capped for length. Field definitions, types, and provenance rules are in the data dictionary.

Pancreatic necrosis is a serious complication of acute pancreatitis. Pancreatic necrosis involves the irreversible death of pancreatic tissue, which can lead to severe health issues, including infections and an increased risk of death. An endoscopic procedure called direct endoscopic necrosectomy (DEN) is typically performed to remove this necrotic pancreatic tissue as a minimally invasive treatment. This procedure is performed using a thin, flexible, lighted tube called an endoscope and endoscopic instruments that are used with working channels through the scope. Current methods for removing necrotic tissue involve using endoscopic devices such as snares, baskets, nets, and forceps. However, these standard methods are often not very effective because the necrotic tissue can be sticky and hard to grasp. This DEN procedure is part of regular clinical care to treat this condition and remove necrotic tissue from the pancreas. For this research study, the same DEN procedure will be followed with the exception of the device used for the removal of the necrotic tissue. Instead of using forceps, snares, or other traditional tools, a cryoprobe will be used. Cryoprobes work by using extremely cold temperatures to freeze and adhere to the necrotic tissue, making it easier to remove. This method might be better because it can secure larger tissue samples and potentially reduce complications associated with traditional methods. Cryotechnology is successfully used in endoscopy to remove necrotic tissue, foreign bodies and more, but has not been extensively tested in pancreatic …

Source record: https://clinicaltrials.gov/study/NCT06553651

Facts

registry idNCT06553651
primary registryclinicaltrials-gov
recruitment statusRECRUITING
phasenot reported
study typeINTERVENTIONAL
lead conditionPancreatic Necrosis
sponsorChristopher C. Thompson, MD, MSc
sponsor classOTHER
enrollment20
start date2026-12
primary completion2028-12
completion2029-06
results postednot reported

Conditions

  • Pancreatic Necrosis
  • Acute Pancreatitis
  • Acute Pancreatic Necrosis
  • Necrosis
  • Necrosis Pancreas
  • Walled-Off Pancreatic Necrosis

Interventions

  • Cryotechnology Necrosectomy Procedure

Countries

  • United States

Intervention types: DEVICE

Work with this record